Featured Clinical Trial: Chemoprevention of Recurrent Bladder Cancer

PsycEXTRA Dataset ◽

10.1037/e378392004-010 ◽

2004 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Recurrent Bladder Cancer

Download Full-text

Faculty Opinions recommendation of Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739122585.793581022 ◽

2020 ◽

Author(s):

Otto Hemminki

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Repeat Dose ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial protocol

BJU International ◽

10.1111/bju.15365 ◽

2021 ◽

Author(s):

Andrew Moe ◽

Elizabeth Liow ◽

Andrew Redfern ◽

Nicole Swarbrick ◽

Tom Ferguson ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

High Risk ◽

Phase I ◽

Trial Protocol ◽

Muscle Invasive Bladder Cancer ◽

Dose Escalation Study ◽

Muscle Invasive

Download Full-text

1751 OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR RECURRENT BLADDER CANCER FOLLOWING PRIOR PARTIAL CYSTECTOMY

The Journal of Urology ◽

10.1016/j.juro.2012.02.1767 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Ross A. Wopat ◽

Eila C. Skinner ◽

Anirban P. Mitra ◽

Jie Cai ◽

Gus Miranda ◽

...

Keyword(s):

Bladder Cancer ◽

Radical Cystectomy ◽

Partial Cystectomy ◽

Recurrent Bladder Cancer

Download Full-text

The effect of a neoadjuvant instillation of chemotherapy in the prevention of recurrences of non-muscle invasive bladder cancer. Preliminary results of the PRECAVE prospective, controlled, randomized clinical trial

European Urology ◽

10.1016/s0302-2838(21)01132-5 ◽

2021 ◽

Vol 79 ◽

pp. S1043-S1044

Author(s):

D.M. Carrión Monsalve ◽

J. Gomez Rivas ◽

C.R. Trelles ◽

C. Ballesteros Ruiz ◽

M. Alvarez-Maestro ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Preliminary Results ◽

Muscle Invasive

Download Full-text

Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2021.11.001 ◽

2021 ◽

Author(s):

Giovanni Cochetti ◽

Jacopo Adolfo Rossi de Vermandois ◽

Vincenza Maulà ◽

Luigi Cari ◽

Rosy Cagnani ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

High Risk ◽

Diagnostic Performance ◽

Invasive Bladder Cancer ◽

Photodynamic Diagnosis ◽

Single Centre ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Reply.

The Journal of Urology ◽

10.1097/ju.0000000000002238 ◽

2021 ◽

Author(s):

Patrick J. Hensley ◽

Ashish M. Kamat

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Trial Design ◽

Clinical Trial Design ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Nonmuscle Invasive Bladder Cancer

Download Full-text

The benefit of a neoadjuvant instillation of chemotherapy in non-muscle invasive bladder cancer: interim analysis of the PRECAVE randomized clinical trial.

10.37554/en-j.arch.esp.urol-20210704-3511-30 ◽

2021 ◽

Author(s):

Diego Carrión ◽

Juan Gómez Rivas ◽

Cristina Ballesteros Ruiz ◽

Mario Álvarez-Maestro ◽

Emilio Ríos González ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Interim Analysis ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial

European Urology Focus ◽

10.1016/j.euf.2018.02.005 ◽

2019 ◽

Vol 5 (5) ◽

pp. 849-852

Author(s):

Peter F.A. Mulders ◽

Luis Martínez-Piñeiro ◽

Axel Heidenreich ◽

Marko Babjuk ◽

Marc Colombel ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Lessons Learned ◽

Invasive Bladder Cancer ◽

Phase 2 ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive

Download Full-text

Prospective randomized clinical trial of chemohyperthermia with mitomycin-C prior to transurethral resection of the bladder and its relationship with the rate of early recurrence in non-muscle invasive bladder cancer: Intermediate analysis

European Urology Open Science ◽

10.1016/s2666-1683(20)33373-5 ◽

2020 ◽

Vol 19 ◽

pp. e1175-e1176

Author(s):

C. Garcia Alvarez ◽

A.C. Plata Bello ◽

J. Plata Bello ◽

M.A. Tamayo Jover ◽

T. Concepción Masip

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Mitomycin C ◽

Transurethral Resection ◽

Early Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Prospective Randomized Clinical Trial ◽

Muscle Invasive

Download Full-text

Recurrent bladder cancer in aging societies: Importance of major histocompatibility complex class I antigen presentation

International Journal of Cancer ◽

10.1002/ijc.33359 ◽

2020 ◽

Author(s):

Edyta Wieczorek ◽

Malgorzata A. Garstka

Keyword(s):

Bladder Cancer ◽

Major Histocompatibility Complex ◽

Major Histocompatibility Complex Class ◽

Antigen Presentation ◽

Class I ◽

Complex Class ◽

Major Histocompatibility ◽

Histocompatibility Complex ◽

Aging Societies ◽

Recurrent Bladder Cancer

Download Full-text